Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × nintedanib × Clear all

NCT01441297 2017-08-25

BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer

Phase 2 Completed

Small Cell Lung Carcinoma